Page last updated: 2024-12-07
abbott 40174
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Abbott 40174: tetrahydropyridobenzopyran derived from cannabinoid nucleus; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 99040 |
CHEMBL ID | 66108 |
SCHEMBL ID | 11354855 |
MeSH ID | M0061826 |
Synonyms (36)
Synonym |
---|
5h-(1)benzopyrano(4,3-c)pyridine, 1,2,3,4-tetrahydro-5,5-dimethyl-8-(1,2-dimethylheptyl)-10-hydroxy-2-(2-propynyl)- |
nsc 167790 |
sp-1 (van) |
8-(1,2-dimethylheptyl)-1,3,4,5-tetrahydro-5,5-dimethyl-2-(2-propynyl)-2h-(1)benzopyrano(4,3-c)pyridin-10-ol |
abbott 40174 |
2h-(1)benzopyrano(4,3-c)pyridin-10-ol, 8-(1,2-dimethylheptyl)-1,3,4,5-tetrahydro-5,5-dimethyl-2-(2-propynyl)- |
8-(1,2-dimethylheptyl)-5,5-dimethyl-2-prop-2-ynyl-3,4-dihydro-1h-chromeno[4,3-c]pyridin-10-ol |
{2h-[1]benzopyrano[4,3-c]pyridin-10-ol, 8-(1,2-dimethylheptyl)-1,3,4,5-tetrahydro-5,5-dimethyl-2-(2-propynyl)- |
8-(1,2-dimethylheptyl)-5,5-dimethyl-2-(2-propynyl)-1,3,4,5-tetrahydro-2h-chromeno[4,3-c]pyridin-10-ol |
sp-1 |
nsc-167790 |
nsc167790 |
2h-[1]benzopyrano[4, 8-(1,2-dimethylheptyl)-1,3,4,5-tetrahydro-5,5-dimethyl-2-(2-propynyl)- |
26685-57-4 |
sp 1 (pharmaceutical) |
CHEMBL66108 |
5,5-dimethyl-8-(3-methyloctan-2-yl)-2-prop-2-ynyl-3,4-dihydro-1h-chromeno[4,3-c]pyridin-10-ol |
AKOS001637126 |
5hf6ee0tc4 , |
unii-5hf6ee0tc4 |
a-40174 |
5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4,-tetrahydro-5h-[1]benzopyrano[3,4-d]pyridine |
5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)1,2,3,4-tetrahydro-5h-[1]benzopyrano[3,4-d]pyridine |
5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-[1]benzopyrano [3,4-d]pyridine |
PNEYWTKVWJBOMD-UHFFFAOYSA-N |
5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-[1]benzopyrano[3,4-d]pyridine |
SCHEMBL11354855 |
Q4646872 |
sp-1 (pharmaceutical) |
2h-(1)benzopyrano(4,3-c)pyridin-10-ol, 8-(1,2-dimethylheptyl)-1,3,4,5-tetrahydro-5,5-dimethyl-2-(2-propyn-1-yl)- |
abbott-40174 |
8-(1,2-dimethylheptyl)-1,3,4,5-tetrahydro-5,5-dimethyl-2-(2-propyn-1-yl)-2h-(1)benzopyrano(4,3-c)pyridin-10-ol |
5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-(1)benzopyrano(3,4-d)pyridine |
DTXSID00949501 |
5,5-dimethyl-8-(3-methyloctan-2-yl)-2-(prop-2-yn-1-yl)-1,3,4,5-tetrahydro-2h-[1]benzopyrano[4,3-c]pyridin-10-ol |
5,5-dimethyl-8-(3-methyloctan-2-yl)-2-(prop-2-yn-1-yl)-2,3,4,5-tetrahydro-1h-chromeno[4,3-c]pyridin-10-ol |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (67)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1149205 | Antidiarrheal activity in Charles River rat assessed as inhibition of castor oil-induced diarrhea by measuring protected animals at 1 mg/kg, po administered 1 hr prior to castor oil challenge measured after 1 hr relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149105 | Analgesic activity in po dosed Sprague-Dawley rat after 15 to 90 mins by tail flick test | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1150019 | Antipsychotic activity in Long-Evens rat assessed as reduction in methamphetamine-induced hyperactivity at 5 mg/kg, po | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives. |
AID1150011 | Antianxiety activity in albino BALB/cJ mouse assessed as decrease in foot shock-induced fighting behavior at 5 mg/kg, po by tranquilizer activity test | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives. |
AID1149183 | Antisecretory activity in Sprague-Dawley rat assessed as decrease in acid output at 50 mg/kg, po administered 30 mins prior to pylorus ligation measured after 4 hrs relative to control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1150008 | Antidepressant activity in mouse assessed as potentiation of (+/-)Dopa-induced motor responses at 5 mg/kg, po challenged with Dopa after 4 hrs compound treatment | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives. |
AID193396 | Percentage decrease in systolic blood pressure after 4 hr at 10 mg/kg administered perorally in rats | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New antihypertensive cannabinoids. |
AID193398 | Percentage decrease in systolic blood pressure after 4 hr at 3 mg/kg administered perorally in rats | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New antihypertensive cannabinoids. |
AID1149168 | Hypnotic activity in cat assessed as increase in non-REM sleep time at 0.025 mg/kg administered orally through diet measured for 12 hrs by EEG analysis | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID140544 | The compound was tested for activity to decrease fighting in mouse at a dose of 10 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149140 | Antidepressant activity in po dosed mouse assessed as potentiation of DOPA-induced effect administered 4 hrs prior to DOPA challenge | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149219 | Antiulcer activity in albino Sprague-Dawley rat stress ulcer model assessed as prevention of stress-induced gastric lesions by measuring ulcer index score at 40 mg/kg, po administered 30 mins prior to stress measured after 4 hrs | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149117 | Antianxiety activity in albino BALB/cJ mouse assessed as reduction in footshock-induced fighting behavior at 1 mg/kg, po after 30 to 90 mins | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1150017 | Antianxiety activity in po dosed beagle-like dog assessed as minimum dose required to produce moderate ataxia | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives. |
AID1149158 | Hypnotic activity in cat assessed as increase in total sleep time at 0.5 mg/kg administered orally through diet measured for 12 hrs by EEG analysis | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1150009 | Analgesic activity in po dosed Sprague-Dawley rat by tail flick assay | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives. |
AID1132947 | Toxicity in ip dosed Wistar rat assessed as tachycardia | 1978 | Journal of medicinal chemistry, Aug, Volume: 21, Issue:8 | Drugs derived from cannabinoids. 7. Tachycardia and analgesia structure-activity relationships in delta9-tetrahydrocannabinol and some synthetic analogues. |
AID1149166 | Hypnotic activity in cat assessed as increase in non-REM sleep time at 0.5 mg/kg administered orally through diet measured for 12 hrs by EEG analysis | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149222 | Antiulcer activity in albino Sprague-Dawley rat shay ulcer model assessed as ulcer index scores at 40 mg/kg administered intraduodenally post pyloric ligation measured after 18.5 hrs relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID193546 | The compound was tested for methamphetamine antagonism in rat at a dose of 5 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149145 | Antihypertensive activity in spontaneously hypertensive rat model assessed as reduction in blood pressure at 10 mg/kg, po after 24 hrs | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149218 | Acute toxicity in po dosed mouse | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID180354 | The compound was tested for analgesic activity using (RTF) tail-flick test in rat | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149146 | Antihypertensive activity in spontaneously hypertensive rat model assessed as reduction in blood pressure at 3 mg/kg, po after 3 hrs | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1150022 | Sedative-hypnotic activity in cat assessed as change in total sleep time at 0.1 mg/kg, po after 12 hrs | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives. |
AID1149133 | Antipsychotic activity in rat assessed as reduction of methamphetamine-induced hyperactivity at 10 mg/kg, po administered prior to methamphetamine challenge relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1132949 | Analgesic activity in po dosed mouse by anti-writhing test | 1978 | Journal of medicinal chemistry, Aug, Volume: 21, Issue:8 | Drugs derived from cannabinoids. 7. Tachycardia and analgesia structure-activity relationships in delta9-tetrahydrocannabinol and some synthetic analogues. |
AID193547 | The compound was tested for methamphetamine antagonism in rat at a dose of 80 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149132 | Antipsychotic activity in rat assessed as reduction of methamphetamine-induced hyperactivity at 5 mg/kg, po administered prior to methamphetamine challenge relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID193392 | Percentage decrease in systolic blood pressure after 24 hr at 3 mg/kg administered perorally in rats | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New antihypertensive cannabinoids. |
AID1149220 | Antiulcer activity in albino Sprague-Dawley rat reserpine ulcer model assessed as prevention of reserpine-induced gastric lesions by measuring ulcer index scores at 50 mg/kg, po administered 30 mins prior to reserpine challenge measured after 6 hrs | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID195164 | The compound was tested for hyperexcitability in rat at a dose of 10 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149169 | Hypnotic activity in cat assessed as increase in non-REM sleep time at 0.1 mg/kg administered orally through diet measured for 12 hrs by EEG analysis | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID193550 | The compound was tested for serotonin antagonism in rat at a dose of 20 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID193536 | The compound was tested for decreasing motor activity in rat at a dose of 10 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149215 | Antiulcer activity in albino Sprague-Dawley rat shay ulcer model assessed as ulcer index scores at 20 mg/kg administered intraduodenally post pyloric ligation measured after 18.5 hrs relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149131 | Antianxiety activity in po dosed dog assessed as ataxia administered as single dose measured up to 24 hrs | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149223 | Antiulcer activity in albino Sprague-Dawley rat shay ulcer model assessed as ulcer index scores at 50 mg/kg administered intraduodenally post pyloric ligation measured after 18.5 hrs relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID140546 | The compound was tested for activity to decrease fighting in mouse at a dose of 5 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149104 | Antianxiety activity in Long-Evans rat assessed as reduction in motor activity at 1 mg/kg, po after 2 hrs relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149161 | Hypnotic activity in cat assessed as increase in total sleep time at 0.1 mg/kg administered orally through diet measured for 12 hrs by EEG analysis | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149144 | Antihypertensive activity in spontaneously hypertensive rat model assessed as reduction in blood pressure at 10 mg/kg, po after 3 hrs | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149213 | Antiulcer activity in albino Sprague-Dawley rat stress ulcer model assessed as prevention of stress-induced gastric lesions by measuring ulcer index score at 10 mg/kg, po administered 30 mins prior to stress measured after 4 hrs | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149120 | Antianxiety activity in Long-Evans rat assessed as reduction in motor activity at 10 mg/kg, po after 2 hrs relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID193391 | Percentage decrease in systolic blood pressure after 24 hr at 10 mg/kg administered perorally in rats | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New antihypertensive cannabinoids. |
AID1149195 | Antisecretory activity in Sprague-Dawley rat assessed as decrease in pepsin output at 50 mg/kg, po administered 30 mins prior to pylorus ligation measured after 4 hrs relative to control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149214 | Antiulcer activity in albino Sprague-Dawley rat reserpine ulcer model assessed as prevention of reserpine-induced gastric lesions by measuring ulcer index scores at 10 mg/kg, po administered 30 mins prior to reserpine challenge measured after 6 hrs | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149178 | Antisecretory activity in Sprague-Dawley rat assessed as decrease in acidity at 50 mg/kg, po administered 30 mins prior to pylorus ligation measured after 4 hrs relative to control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1150010 | Analgesic activity in po dosed mouse assessed as inhibition of acetic acid-induced writhing | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives. |
AID1149147 | Antihypertensive activity in spontaneously hypertensive rat model assessed as reduction in blood pressure at 3 mg/kg, po after 24 hrs | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149228 | Antidiarrheal activity in Charles River rat assessed as inhibition of castor oil-induced diarrhea by measuring protected animals at 0.25 mg/kg, po administered 1 hr prior to castor oil challenge measured after 1 hr relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1150015 | Antianxiety activity in Long-Evens rat assessed as decrease in motor activity at 10 mg/kg, po by tranquilizer activity test | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives. |
AID1149115 | Antianxiety activity in albino BALB/cJ mouse assessed as reduction in footshock-induced fighting behavior at 10 mg/kg, po after 30 to 90 mins | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID193545 | The compound was tested for methamphetamine antagonism in rat at a dose of 20 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149172 | Antisecretory activity in Sprague-Dawley rat assessed as decrease in volume at 50 mg/kg, po administered 30 mins prior to pylorus ligation measured after 4 hrs relative to control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID193552 | The compound was tested for serotonin antagonism in rat at a dose of 80 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149123 | Antianxiety activity in Long-Evans rat assessed as reduction in motor activity at 0.5 mg/kg, po after 2 hrs relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149156 | Hypnotic activity in cat assessed as increase in total sleep time at 1 mg/kg administered orally through diet measured for 12 hrs by EEG analysis | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149103 | Analgesic activity in po dosed mouse assessed as inhibition of acetic acid-induced writhing administered 30 mins prior to acetic acid challenge measured after 5 mins for 20 mins | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID132466 | The compound was tested for analgesic activity using writhing (W) test in mouse | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1132948 | Analgesic activity in po dosed mouse by hot plate test | 1978 | Journal of medicinal chemistry, Aug, Volume: 21, Issue:8 | Drugs derived from cannabinoids. 7. Tachycardia and analgesia structure-activity relationships in delta9-tetrahydrocannabinol and some synthetic analogues. |
AID1149160 | Hypnotic activity in cat assessed as decrease in total sleep time at 0.025 mg/kg administered orally through diet measured for 12 hrs by EEG analysis | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149201 | Antidiarrheal activity in Charles River rat assessed as inhibition of castor oil-induced diarrhea by measuring protected animals at 0.5 mg/kg, po administered 1 hr prior to castor oil challenge measured after 1 hr relative to vehicle-treated control | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID1149170 | Hypnotic activity in cat assessed as increase in non-REM sleep time at 0.25 mg/kg administered orally through diet measured for 12 hrs by EEG analysis | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID195166 | The compound was tested for hyperexcitability in rat at a dose of 5 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
AID1149162 | Hypnotic activity in cat assessed as increase in total sleep time at 0.25 mg/kg administered orally through diet measured for 12 hrs by EEG analysis | 1976 | Journal of medicinal chemistry, Apr, Volume: 19, Issue:4 | Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. |
AID193551 | The compound was tested for serotonin antagonism in rat at a dose of 5 mg/Kg | 1983 | Journal of medicinal chemistry, Feb, Volume: 26, Issue:2 | New azacannabinoids highly active in the central nervous system. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |